Share This Article:

Paraneoplastic Leukemoid Reaction in a Patient with Urothelial Carcinoma: A Case Report

Abstract Full-Text HTML XML Download Download as PDF (Size:204KB) PP. 249-252
DOI: 10.4236/crcm.2014.35057    3,113 Downloads   4,490 Views   Citations


Introduction: Leukemoid reactions in cancer are rare and associated with a poor prognosis. The mechanism driving paraneoplastic leukemoid reactions appears to be gain-of-function granulocyte-colony stimulating factor (G-CSF) secretion by tumour cells. Case Presentation: A 57-year-old male smoker presented with a one-year history of painless frank hematuria and three kilograms weight loss. Cystoscopy revealed a high-grade urothelial carcinoma with sarcomatoid differentiation. The patient was treated by radical cystoprostatectomy, bilateral pelvic lymph node dissection and formation of an ileal conduit. In the absence of bone marrow infiltrations, recurrence of the urothelial carcinoma three months later was associated with a paraneoplastic leukemoid reaction with a white blood cell count peaking at 82.62 × 109/l. Unfortunately, his condition continued to deteriorate and he died shortly thereafter. Conclusion: Monitoring of white blood cell counts in paraneoplastic leukemoid reactions can be a useful indicator of response of the malignancy to chemotherapy or radiotherapy and an indication of relapse after treatment. Paraneoplastic leukemoid reactions are caused by G-CSF secretion by tumour cells and are associated with a poor prognosis. Whether G-CSF signaling plays a role in the aggressive nature of these cancers is currently unknown.

Cite this paper

Suo, A. and Abbas, T. (2014) Paraneoplastic Leukemoid Reaction in a Patient with Urothelial Carcinoma: A Case Report. Case Reports in Clinical Medicine, 3, 249-252. doi: 10.4236/crcm.2014.35057.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] George, T.I. (2012) Malignant or Benign Leukocytosis. Hematology, 2012, 475-484.
[2] Sakka, V., Tsiodras, S., Giamarellos-Bourboulis, E.J. and Giamarellou, H. (2006) An Update on the Etiology and Diagnostic Evaluation of a Leukemoid Reaction. European Journal of Internal Medicine, 17, 394-398.
[3] Schniewind, B., Christgen, M., Hauschild, A., Kurdow, R., Kalthoff, H. and Klomp, H.J. (2005) Paraneoplastic Leukemoid Reaction and Rapid Progression in a Patient with Malignant Melanoma. Cancer Biology & Therapy, 4, 23-27.
[4] Ohbayashi, H., Nosaka, H., Hirose, K., Yamase, H., Yamaki, K. and Ito, M. (1999) Granulocyte Colony Stimulating Factor-Producing Diffuse Malignant Mesothelioma of Pleura. Internal Medicine, 38, 668-670.
[5] Jardin, F., Vasse, M., Debled, M., Dominique, S., Courville, P., Callonnec, F., Buchonnet, G., et al. (2005) Intense Paraneoplastic Neutrophilic Leukemoid Reaction Related to a G-CSF Secreting Lung Sarcoma. American Journal of Hematology, 80, 243-245.
[6] Ito, N., Matsuda, T., Kakehi, Y., Takeuchi, E., Takahashi, T. and Yoshida, O. (1990) Bladder Cancer Producing Granulocyte Colony-Stimulating Factor. New England Journal of Medicine, 323, 1709-1710.
[7] Mizutani, Y., Okada, Y., Terachi, T., Kakehi, Y. and Yoshida, O. (1995) Serum Granulocyte Colony-Stimulating Factor Levels in Patients with Urinary Bladder Tumour and Various Urological Malignancies. British Journal of Urology, 76, 580-586.
[8] Nara, T., Hayakawa, A., Ikeuchi, A., Katoh, N. and Kishimoto, S. (2003) Granulocyte Colony-Stimulating Factor-Producing Cutaneous Angiosarcoma with Leukaemoid Reaction Arising on a Burn Scar. British Journal of Dermatology, 149, 1273-1275.
[9] Nimieri, H.S., Makoni, S.N., Madziwa, F.H. and Nemiary, D.S. (2003) Leukemoid Reaction Response to Chemotherapy and Radiotherapy in a Patient with Cervical Carcinoma. Annals of Hematology, 82, 316-317.
[10] McKee, L.C. (1985) Excess Leukocytosis (Leukemoid Reactions) Associated with Malignant Diseases. South Medical Journal, 78, 1475-1482.
[11] Miller, J.I., Sarver, R.G. and Drach, G.W. (1994) Leukemoid Reaction: A Rare Paraneoplastic Syndrome Associated with Advanced Bladder Carcinoma. Urology, 44, 444-446.
[12] Tachibana, M. and Murai, M. (1998) G-CSF Production in Human Bladder Cancer and Its Ability to Promote Autocrine Growth: A Review. Cytokines Cellular Molecular Therapy, 4, 113-120.
[13] Dukes, J.W. and Tierney, L.M. (2009) Paraneoplastic Leukemoid Reaction as Marker for Transitional Cell Carcinoma Recurrence. Urology, 73, 17-19.
[14] Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., et al. (2005) G-CSF Prevents Cardiac Remodeling after Myocardial Infarction by Activating the Jak-Stat Pathway in Cardiomyocytes. Natural Medicine, 11, 305-311.
[15] Natori, T., Sata, M., Washida, M., Hirata, Y., Nagai, R. and Makuuchi, M. (2002) G-CSF Stimulates Angiogenesis and Promotes Tumor Growth: Potential Contribution of Bone Marrow-Derived Endothelial Progenitor Cells. Biochemical and Biophysical Research Communications, 297, 1058-1061.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.